Business Context and Reporting Period
Company: Weis Markets, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 29, 2007
Operations: The company operates 155 retail food stores in Pennsylvania and four surrounding states, plus 31 SuperPetz pet supply stores across ten states. It reports as a single segment.
Key Financial Metrics
| Metric (in thousands) | 13 Weeks Ended Sept 29, 2007 |
39 Weeks Ended Sept 29, 2007 |
|---|---|---|
| Net Sales | $564,966 | $1,715,573 |
| Gross Profit | $147,694 | $453,447 |
| Gross Margin % | 26.1% | 26.4% |
| Operating Income | $15,223 | $62,627 |
| Net Income | $10,817 | $42,380 |
| Earnings Per Share (Diluted) | $0.40 | $1.57 |
| Cash from Operations | N/A | $72,327 |
| Cash & Equivalents (Ending) | $55,545 | $55,545 |
| Total Debt | None reported | None reported |
Note: The company carries no long-term debt. Working capital increased $15.1 million year-to-date.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 1.4% in Q3 and 2.9% year-to-date (YTD) compared to 2006.
- Comparable Store Sales: Q3 comparable sales rose 1.8% (vs. 3.2% in 2006); YTD comparable sales rose 3.0% (vs. 2.0% in 2006). Growth was driven by higher transaction values, while store visits remained flat.
- Profitability: Q3 Net Income decreased 6.5% to $10.8 million. YTD Net Income increased 0.9% to $42.4 million.
- Expense Drivers: Operating expenses decreased as a percentage of sales due to a $2.7 million pre-tax gain on the sale of a closed store facility in Q3 (compared to a $1.7 million impairment loss in Q3 2006). YTD gains on asset sales totaled $8.2 million.
- Cost Pressures: Store labor expenses increased due to Pennsylvania's minimum wage hikes and rate increases in neighboring states. Credit/debit card interchange fees rose 8.9% in the quarter.
Outlook, Risks, and Management Commentary
- Pharmacy Trends: Sales are negatively impacted by the shift from brand-name to generic prescriptions and the migration of Medicare D prescriptions to mail-order services. Management does not foresee a reversal of this trend.
- Capital Expenditures: The company plans to invest approximately $72.5 million in 2007 for new superstores, remodels, and technology upgrades. YTD capital expenditures were $45.5 million.
- Liquidity: The company anticipates funding operations and expansion through internally generated cash flows. Cash dividends of $0.29 per share were approved for payment in November 2007.
- Risks: Key risks include general economic conditions, competitive pressures from regional and national retailers, rising interchange fees, and regulatory changes. The company is actively lobbying to reduce interchange rates.
- Inventory Control: Management attributed a reduction in gross profit rate to poor inventory control at the store level and is implementing new exception reporting tools to improve shrink control.
Investor Verification Checklist
- Pharmacy Revenue: Verify the specific dollar impact of the shift to generic and mail-order prescriptions on future revenue projections.
- Inventory Shrinkage: Monitor the effectiveness of the new exception reporting application in reversing the trend of poor inventory control.
- Interchange Fees: Track the outcome of legislative and regulatory initiatives aimed at reducing credit/debit card processing fees.
- Capital Allocation: Confirm that the $72.5 million capital expenditure plan is on track and funded by operating cash flows without requiring external financing.
- Comparable Sales Quality: Analyze whether the increase in average transaction size is sustainable given flat customer store visits.